LAUSR

Nowadays hepatitis C can be cured in nearly all affected people by extremely effective and safe therapies, therefore the current challenges are case finding and access to treatment. The latest estimates by the WHO report 58 million hepatitis C cases around the world and about 1.5 million new infections per year.1 Some experts believe that the Global Health Sector Strategy goal of eliminating viral hepatitis ‘as a major public health threat’ by 20301 is somewhat optimistic in relation to the current global situation.2 The SARSCoV2 pandemic has hampered the hepatitis C testing and treatment,3 and it is estimated that it could be a major obstacle to hepatitis C elimination.3,4 Among the efforts to counter this scenario, it was proposed to exploit the current pandemic to enhance hepatitis C screening.5 The first experiences of combined HCV/SARSCoV2 testing have already been carried out,6,7 while although it was proposed,8 there are still no data on the combination of screening for hepatitis C and SARSCoV2 vaccination. For these reasons, we started a screening program for hepatitis C simultaneously with the SARSCoV2 testing or vaccination. This project took place in an urban area in the province of Salerno (Campania region).